End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
117.2 CNY | +8.98% | +11.70% | -6.93% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
Sales 2024 * | 3.19B 441M | Sales 2025 * | 4.15B 573M | Capitalization | 18.4B 2.54B |
---|---|---|---|---|---|
Net income 2024 * | 633M 87.39M | Net income 2025 * | 836M 115M | EV / Sales 2024 * | 5.97 x |
Net Debt 2024 * | 664M 91.66M | Net Debt 2025 * | 312M 43.13M | EV / Sales 2025 * | 4.51 x |
P/E ratio 2024 * |
29.2
x | P/E ratio 2025 * |
22.1
x | Employees | - |
Yield 2024 * |
1.06% | Yield 2025 * |
1.29% | Free-Float | 55.99% |
1 day | +8.98% | ||
1 week | +11.70% | ||
Current month | +4.63% | ||
1 month | +4.63% | ||
3 months | +17.56% | ||
6 months | +18.32% | ||
Current year | -6.93% |
Managers | Title | Age | Since |
---|---|---|---|
Geng Hua Guo
CEO | Chief Executive Officer | 60 | 05-04-12 |
Yi Fan
DFI | Director of Finance/CFO | 47 | 15-12-31 |
Xue Li Zhang
CTO | Chief Tech/Sci/R&D Officer | 43 | 13-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Feng Zhang
BRD | Director/Board Member | 51 | 19-07-31 |
Lin Wu
BRD | Director/Board Member | 65 | 22-06-27 |
Heng Ping Guo
FOU | Founder | 62 | 05-04-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.43% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 117.2 | +8.98% | 1,499,699 |
24-04-26 | 107.5 | +0.49% | 703,779 |
24-04-25 | 107 | -0.29% | 459,218 |
24-04-24 | 107.3 | +2.10% | 655,531 |
24-04-23 | 105.1 | +0.19% | 1,103,590 |
End-of-day quote Shanghai S.E., April 28, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.93% | 2.54B | |
+4.27% | 30.36B | |
+9.31% | 11.89B | |
+14.40% | 5.24B | |
+13.93% | 4.32B | |
-15.09% | 3.54B | |
-2.50% | 3.21B | |
+4.91% | 3.12B | |
+27.99% | 2.8B | |
+4.58% | 2.4B |
- Stock Market
- Equities
- 688639 Stock